ACCL (ACCL) Stock Price & Analysis
ACCL (ACCL) fell 1.94% to USD 1.52 as of June 10, 2026 at 02:25 UTC, according to Nexqual real-time market data.
ACCL last closed at USD 1.55; the session ranged USD 1.45–1.88 on volume of 1,204,169 shares. Market capitalization is $21.20M, with a 52-week range of USD 1.23–5 (NCM). Source: Nexqual, June 10, 2026 at 02:25 UTC.
Key Statistics (as of June 10, 2026 at 02:25 UTC)
| Price | USD 1.52 |
|---|---|
| Change | ▼ 1.94% (down) |
| Previous Close | USD 1.55 |
| Open | USD 1.51 |
| Day Range | USD 1.45 – 1.88 |
| 52-Week Range | USD 1.23 – 5 |
| Volume | 1,204,169 shares |
| Market Cap | $21.20M |
| Exchange | NCM |
Technical Analysis (ACCL)
Nexqual's technical model rates ACCL "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 02:25 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.71 (neutral) |
| vs SMA50 | Above (USD 1.45) |
| MACD | 0.01 (positive) |
Analyst Ratings (ACCL)
Wall Street analysts rate ACCL "None", per Nexqual as of June 10, 2026 at 02:25 UTC.
| Consensus Rating | None |
|---|
Earnings (ACCL)
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Financials & Fundamentals (ACCL)
| Total Revenue | $4.89M |
|---|---|
| Revenue Growth (YoY) | +0.70% |
| Gross Margin | +43.77% |
| Operating Margin | +21.96% |
| Profit Margin | +20.90% |
| ROE | +61.27% |
| Debt / Equity | 12.52 |
| Current Ratio | 1.82 |
| Total Cash | $2.52M |
| Total Debt | $273,814 |
| Free Cash Flow | $1.86M |
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Financial Health Score (ACCL)
Nexqual rates ACCL's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 02:25 UTC.
| Growth | Mixed — Revenue +0.7% YoY (latest Q), slow |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $3M cash, no debt |
| Cash Flow | Strong — FCF $2M, 38% margin |
| Efficiency | Strong — ROE 61%, ROA 20.5% |
Ownership (ACCL)
| Insider Ownership | +92.16% |
|---|---|
| Institutional Ownership | +0.13% |
| Shares Outstanding | 13.95M |
| Float | 2.93M |
| Short % of Float | +1.63% |
Source: Nexqual, June 10, 2026 at 02:25 UTC.
Leadership (ACCL)
ACCL is led by Cheung Po Lui (age 44), CEO & Director, per Nexqual as of June 10, 2026 at 02:25 UTC.
| CEO & Director | Cheung Po Lui (age 44) |
|---|---|
| CFO & Chairman | Yuen Yuk Hau (age 43) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SKYE | Skye Bioscience, Inc. | USD 0.75 | ▲ 2.46% |
| SLSN | Solesence, Inc. | USD 1.22 | ▼ 6.87% |
| NVEC | NVE Corporation | USD 105.17 | ▲ 3% |
| ALTI | AlTi Global, Inc. | USD 2.81 | ▼ 5.7% |
| VECO | Veeco Instruments Inc. | USD 67.19 | ▲ 14.95% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:25 UTC. This page is informational and not investment advice.